Zentalis Pharmaceuticals, Inc. Common Stock (NASDAQ: ZNTL) last traded at $2.40, down 4.76% on the session. The quote above updates while this page is open; the figures below are drawn from Zentalis Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Zentalis Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker ZNTL. Its market capitalisation is $172.01 million.
Valuation measures for Zentalis Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $172.01M |
|---|---|
| Enterprise value | $218.91M |
| Price / book | 1.20 |
| Beta | 2.01 |
Trailing-twelve-month figures tagged in Zentalis Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$139.54M |
|---|
| EPS (TTM) | -$1.96 |
|---|
| Return on equity | -97.15% |
|---|
| Cash | $24.78M |
|---|
Range and volume for ZNTL over the past 52 weeks.
| 52-week high | $6.95 |
|---|---|
| 52-week low | $1.21 |
| Volume | 570.1K |
| Average volume | 1.18M |
| Previous close | $2.52 |
Invest a chosen dollar amount in Zentalis Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ZNTL.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.